CAR T-cell therapy for relapsed or refractory mantle-cell lymphoma

Lancet Oncol. 2020 May;21(5):e239. doi: 10.1016/S1470-2045(20)30231-X. Epub 2020 Apr 9.
No abstract available

Publication types

  • Comment

MeSH terms

  • Adult
  • Humans
  • Immunotherapy, Adoptive*
  • Lymphoma, Mantle-Cell*